{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:14:00Z","timestamp":1786976040591,"version":"build-2736575974"},"reference-count":59,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003465","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T17:14:00Z","timestamp":1069434840000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Therapies for depression in Parkinson's disease"],"prefix":"10.1002","author":[{"given":"Shabnam","family":"Ghazi-Noori","sequence":"first","affiliation":[{"name":"City Hospital NHS Trust; Department of Neurology; Dudley Road Birmingham West Midlands UK B18 7QH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin Hei","family":"Chung","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Deane","sequence":"additional","affiliation":[{"name":"Newcastle University; Institute of Health & Society; 21 Claremont Place Newcastle-upon-Tyne UK NE2 4AA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh E","family":"Rickards","sequence":"additional","affiliation":[{"name":"Birmingham and Solihull Mental Health Trust; Neuropsychiatry; Mindelsohn Way Birmingham West Midlands UK B15 2QZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E","family":"Clarke","sequence":"additional","affiliation":[{"name":"City Hospital, Sandwell and West Birmingham Hospitals NHS Trust; Department of Neurology; Dudley Road Birmingham West Midlands UK B18 7QH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,4,22]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD003465-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.1980.tb03028.x","article-title":"Anti-depressive treatment in Parkinson's disease A controlled trial of the effect of nortiptyline in patients with Parkinson's disease treated with L-dopa","volume":"62","author":"Andersen","year":"1980","journal-title":"Acta Neurologica Scandinivica"},{"key":"10.1002\/14651858.CD003465-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.1980.tb03028.x","article-title":"Anti-depressive treatment in Parkinson's disease. A controlled trial of the effects of nortriptyline in patients with Parkinson's disease treated with L-dopa","volume":"62","author":"Andersen","year":"1980","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD003465-BIB0003|cit3","first-page":"A374","article-title":"Comparison of Fluvoxamine versus Amitriptyline for treatment of depression in Parkinson's disease","volume":"46","author":"Rabey","year":"Feb 1996","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003465-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08039489850139049","article-title":"Depression in idiopathic Parkinson's disease treated with citalopram- A placebo-controlled trial","volume":"52","author":"Wermuth","year":"1998","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003465-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0404.1991.tb05024.x","article-title":"Selegiline in de novo Parkinsonian patients: The French Selegiline Multicenter trial (FSMT)","volume":"136 [Supp]","author":"Allain","year":"1991","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD003465-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1002\/mds.870080508","article-title":"Symtomatic effect of selegiline in de novo Parkinsonian patients. The French Selegiline Multicenter Trial","volume":"8 [Suppl 1]","author":"Allain","year":"1993","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1002\/14651858.CD003465-BIB0007|cit7","first-page":"63","article-title":"The phototherapy of Parkinsonism patients","volume":"96","author":"Artemenko","year":"1996","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"},{"key":"10.1002\/14651858.CD003465-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"187S","DOI":"10.1111\/j.1365-2125.1977.tb05751.x","article-title":"Nomifensine in Parkinson's disease","volume":"4","author":"Bedard","year":"1977","journal-title":"Br. J. Clin Pharmac."},{"issue":"7-8","key":"10.1002\/14651858.CD003465-BIB0009|cit9","first-page":"499","article-title":"Clomipramine, depression and Parkinson's disease","volume":"18","author":"Boer","year":"1976","journal-title":"TPSYCHIAT"},{"issue":"3","key":"10.1002\/14651858.CD003465-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0033-3182(88)72375-0","article-title":"Electroconvulsive therpay in the treatment of combined depression and Parkinson's disease","volume":"29","author":"Burke","year":"1988","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD003465-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jnnp.52.6.724","article-title":"Major depression in Parkisnon's disease and the mood response to intravenous methylphenidate: possible role of the \"hedonic\" dopamine synapse","volume":"52","author":"Cantello","year":"1989","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003465-BIB0012|cit12","first-page":"154","article-title":"S-adenosylmethionine treatment of depression in patients with Parkinson's disease","volume":"48","author":"Carrieri","year":"1990","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003465-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1212\/WNL.55.8.1216","article-title":"Paroxetine in Parkinson's disease: Effects on motor and depressive symptoms","volume":"55","author":"Ceravolo","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003465-BIB0014|cit14","first-page":"102","article-title":"Psychological intervention for Parkinson patients","volume":"7 [Suppl 1]","author":"Ellgring","year":"1992","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003465-BIB0015|cit15","first-page":"49","article-title":"Experience with tranylcypromine in early Parkinson's disease","volume":"52 [Supp]","author":"Fahn","year":"1998","journal-title":"J. Neural Transm"},{"key":"10.1002\/14651858.CD003465-BIB0016|cit16","first-page":"137","article-title":"Therapeutic efficacy of R-(-)deprenyl as adjuvant therapy in advanced Parkinsonism","volume":"25 [Supp]","author":"Fischer","year":"1987","journal-title":"J. Neural Transmission"},{"key":"10.1002\/14651858.CD003465-BIB0017|cit17","first-page":"176","article-title":"Fluoxetine and depression in patients with idopathic Parkinson's disease","volume":"13","author":"Foy","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003465-BIB0018|cit18","first-page":"102","article-title":"Fluoxetine in Parkinson's disease","volume":"7 [Suppl 1]","author":"Friedman","year":"1992","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003465-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1353-8020(97)00028-X","article-title":"Treatement of depression in Parkinson's disease with moclobemide: a pilot open-study","volume":"3","author":"Gimenez-Roldan","year":"1997","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1002\/14651858.CD003465-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.34.8.1092","article-title":"Bupropion in Parkinson's disease","volume":"34","author":"Goetz","year":"1984","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003465-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/mds.870120522","article-title":"Sertraline for the treatment of depression in Parkinson's disease","volume":"12","author":"Hauser","year":"1997","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1002\/14651858.CD003465-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0404.1991.tb04978.x","article-title":"Selegiline and cognitive function in Parkinson's disease","volume":"84","author":"Hietanen","year":"1991","journal-title":"Acta Neurologica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD003465-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.38.11.1720","article-title":"Amitriptyline in the treatment of headache in patients with Parkinson's disease: a double-blind placebo-controlled study","volume":"38","author":"Indaco","year":"1988","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003465-BIB0024|cit24","first-page":"544","article-title":"Desipramine in treatment of Parkinson's disease","volume":"45","author":"Laitinen","year":"1969","journal-title":"Acta Neurologica Scandinivica"},{"issue":"Oct","key":"10.1002\/14651858.CD003465-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(77)90725-5","article-title":"Deprenyl in Parkinson's disease","author":"Lees","year":"1977","journal-title":"The Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003465-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-510X(98)00318-9","article-title":"Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation","volume":"162","author":"Mally","year":"1999","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD003465-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/(SICI)1097-4547(19990915)57:6<935::AID-JNR19>3.0.CO;2-8","article-title":"Therapeutic and \"dose dependent\" effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease","volume":"57","author":"Mally","year":"1999","journal-title":"Journal of Neuroscience Research"},{"issue":"3","key":"10.1002\/14651858.CD003465-BIB0028|cit28","first-page":"622","article-title":"Sertraline for the treatment of depression in Parkinson's disease","volume":"13","author":"Meara","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003465-BIB0029|cit29","first-page":"243","article-title":"An open uncontolled study of the use of sertraline in the treatment of depression in Parkinson's disease","volume":"4","author":"Meara","year":"1996","journal-title":"Journal of Serotonin Research"},{"issue":"3","key":"10.1002\/14651858.CD003465-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mds.870120308","article-title":"Short-term effects of behavioural treatment on movement initiation and postural control in Parkinson's disease: a controlled clinical study","volume":"12","author":"Muller","year":"1997","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003465-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1111\/j.1365-2125.1977.tb05750.x","article-title":"Nomifensine in Parkinsonism","volume":"4","author":"Park","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003465-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jnnp.60.6.693","article-title":"Electroconvulsive therapy in Parkinson's disease: 30 months of follow up","volume":"61","author":"Pridmore","year":"1996","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003465-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jnnp.58.5.641-a","article-title":"Electroconvulsive therapy for the physical signs of Parkinson's disease without depressive disorders","volume":"58","author":"Pridmore","year":"1995","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003465-BIB0034|cit34","unstructured":"Rektorova I Rektor I Hortova H Bares M Ehler E Fiedler J Ressner P Urbanek K Veliskova J Svatova J Kulistak P Fanfrdlova Z Depression in Parkinson's disease: an eight-month, randomized, open label, national, multi-centre comparative study of pramipexole and pergolide"},{"key":"10.1002\/14651858.CD003465-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000116869","article-title":"An interim report of the effect of selegiline (L-Deprenyl) on the progression of disability in early Parkinson's disease","volume":"32 [suppl 1]","author":"Shoulson","year":"1992","journal-title":"Eur Neurol"},{"issue":"4 [suppl 2]","key":"10.1002\/14651858.CD003465-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1097\/00004714-199508001-00010","article-title":"The therapeutic potential of mocloemide, a reversible selecive monoamine oxidase A inhibitor in Parkinson's dsease","volume":"15","author":"Sieradzan","year":"1995","journal-title":"Jounal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD003465-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/jnnp.63.4.547","article-title":"Moclobemide and selegeline in the treatment of depression in Parkinson's disease","volume":"63","author":"Steur","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003465-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/bmj.2.5452.33","article-title":"Imipramine in treatment of Parkinsonism: a double-blind placebo study","volume":"2","author":"Strang","year":"1965","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003465-BIB0039|cit39","unstructured":"Takats A Tarczy M Simo M Szombathelyi E Bodrogi A Karpati R Moclobemide\/aurorix\/ treatment in Parkinson's disease with depression New Trends in Clinical Pharmacology 1994 260"},{"issue":"8","key":"10.1002\/14651858.CD003465-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1532-5415.1997.tb02984.x","article-title":"Nortriptyline for the treatment of depression in progressive supranuclear palsy","volume":"45","author":"Tamai","year":"1997","journal-title":"J. Am Geriatr Soc"},{"key":"10.1002\/14651858.CD003465-BIB0041|cit41","unstructured":"Tarczy MI Szombathelyi E Depression in Parkinson's disease with special regard to anxiety. Experiences with paroxetine treatment Movement Disorders 1998 275"},{"issue":"5","key":"10.1002\/14651858.CD003465-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/1531-8257(200009)15:5<986::AID-MDS1034>3.0.CO;2-I","article-title":"Tolerability of paroxetine in Parkinson's disease: a prospective study","volume":"15","author":"Tesei","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003465-BIB0043|cit43","first-page":"92","article-title":"Moclobemide vs. amineptine in depressed patients with Parkinson's disease","volume":"2","author":"Torun","year":"1995","journal-title":"Eur Neurol"},{"key":"10.1002\/14651858.CD003465-BIB0044|cit44","first-page":"110","article-title":"Treatment of depression in Parkinson's disease in the very old","volume":"14","author":"Trappler","year":"1998","journal-title":"Journal of Pharmacy Technology"},{"issue":"1","key":"10.1002\/14651858.CD003465-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00008877-199501000-00012","article-title":"A double-blind cross-over placebo-controlled trial of the effects of bromocriptine on psychomotor function, cognition, and mood in de novo patients with Parkinson's disease","volume":"6","author":"Weddelll","year":"1995","journal-title":"Behav Pharmacol"},{"key":"10.1002\/14651858.CD003465-BIB0046|cit46","unstructured":"Wittgens W Donath O Trenckmann U Treatment of depressive syndromes in Parkinson's disease (PD) with Paroxetine Movement Disorders 1997 128"},{"issue":"26","key":"10.1002\/14651858.CD003465-BIB0047|cit47","first-page":"1414","volume":"28","author":"Ziegler","year":"1999 (Sept)","journal-title":"La Presse Medicale"},{"key":"10.1002\/14651858.CD003465-BIB0048|cit48","first-page":"186","volume-title":"British National Formulary","author":"Mehta DK","year":"March, 2001"},{"key":"10.1002\/14651858.CD003465-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"The Lancet"},{"issue":"4","key":"10.1002\/14651858.CD003465-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.149.4.443","article-title":"Depression and Parkinson's disease: a review","volume":"149","author":"Cummings","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003465-BIB0051|cit51","volume-title":"Diagnostic and statistical manual of mental disorders - (DSM-IV)","year":"1994"},{"key":"10.1002\/14651858.CD003465-BIB0052|cit52","unstructured":"EPDA http:\/\/www.shef.ac.uk\/misc\/groups\/epda\/parkuk.htm Internet information"},{"key":"10.1002\/14651858.CD003465-BIB0053|cit53","unstructured":"Global Parkinson's Disease Survey PDGS pamphlet 2000?"},{"key":"10.1002\/14651858.CD003465-BIB0054|cit54","first-page":"137","article-title":"Depression treatment in Parkinson's disease","volume":"25","author":"Hart","year":"1991","journal-title":"DICP, The Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD003465-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"3","author":"Hughers","year":"1992","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003465-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1212\/WNL.44.12.2406","article-title":"Parkinsonism exacerbated by paroxetine","volume":"44","author":"Jimenez-Jimenez","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003465-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/jnp.7.3.281","article-title":"Treatment of depression in Parkinson's disease: a meta-analysis","volume":"7","author":"Klaassen","year":"1995","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"S1","key":"10.1002\/14651858.CD003465-BIB0058|cit58","first-page":"1","article-title":"The UKU side effect rating scale","volume":"76","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatria Scandinivica"},{"key":"10.1002\/14651858.CD003465-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson's disease","volume":"69","author":"Schrag","year":"2000","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003465\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:21:05Z","timestamp":1628529665000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003465"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,4,22]]},"references-count":59,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003465","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,22]]}}}